Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Mannitol Dry Powder for inhalation

NICE TA: 266
Indication: Cystic Fibrosis (NICE TA266)
Disease category: Respiratory system
Commissioning responsibility: NHS England
PbR excluded: Yes


Routine funding of dry powder inhalers is agreed only if the cost to commissioners is the same or less than the cost of the equivalent nebules. As the known discount on dry powder inhalers is applied only if supplied via hospital or home delivery, GP shared care prescribing of dry powder inhalers is not supported.


LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA266 - Mannitol dry powder for inhalation for treating cystic fibrosis

GP & CSR CCGs have approved the following RAG status -  Red for new patients/Amber for existing patients

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG



See above